171 related articles for article (PubMed ID: 32532061)
1. A Doxorubicin-Glucuronide Prodrug Released from Nanogels Activated by High-Intensity Focused Ultrasound Liberated β-Glucuronidase.
Besse HC; Chen Y; Scheeren HW; Metselaar JM; Lammers T; Moonen CTW; Hennink WE; Deckers R
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32532061
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of biodegradable and thermosensitive polymeric micelles with covalently bound doxorubicin-glucuronide prodrug via click chemistry.
Talelli M; Morita K; Rijcken CJ; Aben RW; Lammers T; Scheeren HW; van Nostrum CF; Storm G; Hennink WE
Bioconjug Chem; 2011 Dec; 22(12):2519-30. PubMed ID: 22017211
[TBL] [Abstract][Full Text] [Related]
3. Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site.
Mürdter TE; Sperker B; Kivistö KT; McClellan M; Fritz P; Friedel G; Linder A; Bosslet K; Toomes H; Dierkesmann R; Kroemer HK
Cancer Res; 1997 Jun; 57(12):2440-5. PubMed ID: 9192823
[TBL] [Abstract][Full Text] [Related]
4. Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugate.
Houba PH; Boven E; van der Meulen-Muileman IH; Leenders RG; Scheeren JW; Pinedo HM; Haisma HJ
Int J Cancer; 2001 Feb; 91(4):550-4. PubMed ID: 11251980
[TBL] [Abstract][Full Text] [Related]
5. Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin prodrug therapy.
Fonseca MJ; Storm G; Hennink WE; Gerritsen WR; Haisma HJ
J Gene Med; 1999; 1(6):407-14. PubMed ID: 10753066
[TBL] [Abstract][Full Text] [Related]
6. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
[TBL] [Abstract][Full Text] [Related]
7. A facile approach for thermal and reduction dual-responsive prodrug nanogels for intracellular doxorubicin delivery.
Peng H; Huang X; Oppermann A; Melle A; Weger L; Karperien M; Wöll D; Pich A
J Mater Chem B; 2016 Dec; 4(47):7572-7583. PubMed ID: 32263814
[TBL] [Abstract][Full Text] [Related]
8. Redox-responsive degradable prodrug nanogels for intracellular drug delivery by crosslinking of amine-functionalized poly(N-vinylpyrrolidone) copolymers.
Peng H; Huang X; Melle A; Karperien M; Pich A
J Colloid Interface Sci; 2019 Mar; 540():612-622. PubMed ID: 30690386
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives.
Roemhild K; Besse HC; Wang B; Peña Q; Sun Q; Omata D; Ozbakir B; Bos C; Scheeren HW; Storm G; Metselaar JM; Yu H; Knüchel-Clarke R; Kiessling F; Moonen CTW; Deckers R; Shi Y; Lammers T
Theranostics; 2022; 12(10):4791-4801. PubMed ID: 35832083
[No Abstract] [Full Text] [Related]
10. Green-step assembly of low density lipoprotein/sodium carboxymethyl cellulose nanogels for facile loading and pH-dependent release of doxorubicin.
He L; Liang H; Lin L; Shah BR; Li Y; Chen Y; Li B
Colloids Surf B Biointerfaces; 2015 Feb; 126():288-96. PubMed ID: 25576811
[TBL] [Abstract][Full Text] [Related]
11. A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer.
Houba PH; Boven E; van der Meulen-Muileman IH; Leenders RG; Scheeren JW; Pinedo HM; Haisma HJ
Br J Cancer; 2001 Feb; 84(4):550-7. PubMed ID: 11207053
[TBL] [Abstract][Full Text] [Related]
12. Poly(ethylene glycol)-co-methacrylamide-co-acrylic acid based nanogels for delivery of doxorubicin.
Kumar P; Behl G; Sikka M; Chhikara A; Chopra M
J Biomater Sci Polym Ed; 2016 Oct; 27(14):1413-33. PubMed ID: 27383582
[TBL] [Abstract][Full Text] [Related]
13. A facile approach for dual-responsive prodrug nanogels based on dendritic polyglycerols with minimal leaching.
Zhang X; Achazi K; Steinhilber D; Kratz F; Dernedde J; Haag R
J Control Release; 2014 Jan; 174():209-16. PubMed ID: 24225227
[TBL] [Abstract][Full Text] [Related]
14. A methylester of the glucuronide prodrug DOX-GA3 for improvement of tumor-selective chemotherapy.
de Graaf M; Nevalainen TJ; Scheeren HW; Pinedo HM; Haisma HJ; Boven E
Biochem Pharmacol; 2004 Dec; 68(11):2273-81. PubMed ID: 15498517
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Characterization of Dual-Sensitive Fluorescent Nanogels for Enhancing Drug Delivery and Tracking Intracellular Drug Delivery.
Wu SY; Debele TA; Kao YC; Tsai HC
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534813
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic-Acid-Based pH-Sensitive Nanogels for Tumor-Targeted Drug Delivery.
Luan S; Zhu Y; Wu X; Wang Y; Liang F; Song S
ACS Biomater Sci Eng; 2017 Oct; 3(10):2410-2419. PubMed ID: 33445299
[TBL] [Abstract][Full Text] [Related]
17. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
Chen W; Achazi K; Schade B; Haag R
J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
[TBL] [Abstract][Full Text] [Related]
18. Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy.
Ma X; Yang S; Zhang T; Wang S; Yang Q; Xiao Y; Shi X; Xue P; Kang Y; Liu G; Sun ZJ; Xu Z
Acta Pharm Sin B; 2022 Jan; 12(1):451-466. PubMed ID: 35127398
[TBL] [Abstract][Full Text] [Related]
19. Formation of graphene oxide-hybridized nanogels for combinative anticancer therapy.
Xu X; Wang J; Wang Y; Zhao L; Li Y; Liu C
Nanomedicine; 2018 Oct; 14(7):2387-2395. PubMed ID: 28552643
[TBL] [Abstract][Full Text] [Related]
20. pH-responsive targeted and controlled doxorubicin delivery using hyaluronic acid nanocarriers.
Gurav DD; Kulkarni AS; Khan A; Shinde VS
Colloids Surf B Biointerfaces; 2016 Jul; 143():352-358. PubMed ID: 27022876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
